To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Nov 1, 2026 → Mar 1, 2027
See other at-risk trials from Viral N. Shah

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 1 of 1 entry Show 4 more changesShow less
    • Primary completion pushed from Nov 1, 2026 to Mar 1, 2027
    • Study completion pushed from Dec 1, 2026 to Jun 1, 2027
    • Eligibility criteria expanded, about 19 words
    • Secondary endpoints: details revised at 3 of 6 entries
  2. Trial status: Not Yet Recruiting to Recruitingv3 Show 6 more changesShow less
    • Primary endpoint revised
    • Start date changed from estimate of Jan 30, 2026 to Feb 9, 2026
    • Eligibility criteria shortened, about 16 words
    • Secondary endpoints expanded, about 19 words
    • Study description shortened, about 2,161 words
    • Site details revised
  3. Eligibility criteria expanded, about 1 wordv2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Viral N. Shah
1 trial monitored
See 1 trial at risk
Diabetes
5,101 trials monitored
See 233 trials at risk
Type 1 Diabetes
888 trials monitored
See 39 trials at risk
The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.
Trial Details
NCT Number NCT07287943
Lead Sponsor Viral N. Shah
Collaborators: Medtronic
Conditions
(from sponsor)		 Type 1 Diabetes, Gastroparesis Due to Diabetes Mellitus Type I
Related terms Diabetes Mellitus, Type 1, Gastroparesis
Enrollment 34 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov